<DOC>
	<DOCNO>NCT00305630</DOCNO>
	<brief_summary>Randomized control clinical trial periocular corticosteroid adjunctive therapy photodynamic therapy ( PDT ) patient neovascular age-related macular degeneration ( AMD ) . Patients undergo PDT randomize either periocular corticosteroid injection 40 mg triamcinolone acetonide observation prior PDT . Patients follow 6 month . Primary outcome leakage choroidal neovascularization ( CNV ) 3 month fluorescein angiography .</brief_summary>
	<brief_title>Neovascular Age Related Macular Degeneration ( AMD ) , Periocular Corticosteroids , Photodynamic Therapy ( PDT )</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<mesh_term>Wet Macular Degeneration</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Active choroidal neovascularization Age relate macular degeneration Visual acuity 20/20 20/400 Neovascular lesion &gt; 6500 micron great linear diameter More one prior photodynamic therapy treatment Receiving systemic corticosteroid Intraocular pressure &gt; 21 mm Hg glaucoma medication use History glaucoma history ocular hypertension</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2006</verification_date>
	<keyword>Corticosteroids</keyword>
	<keyword>Triamcinolone</keyword>
	<keyword>Photodynamic therapy</keyword>
	<keyword>Choroidal neovascularization</keyword>
	<keyword>Age-related macular degeneration</keyword>
</DOC>